William Hinshaw - 17 Feb 2023 Form 4 Insider Report for Axcella Health Inc.

Role
President & CEO, Director
Signature
/s/ Paul Fehlner, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Feb 2023
Net transactions value
$0
Form type
4
Filing time
24 Feb 2023, 15:18:21 UTC
Previous filing
19 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXLA Stock Option (Right to Buy) Award $0 +275,000 $0.000000 275,000 17 Feb 2023 Common Stock 275,000 $0.6759 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on February 7, 2024, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.